[Role of epimeric glycyrrhizic acid during CPB-induced pulmonary injury in patients undergoing elective cardial valve replacement surgery].
Liao
Qin
Q
Wag
Ming-An
MA
Ouyang
Wen
W
D000328:Adult; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D017558:Elective Surgical Procedures; D005260:Female; D019695:Glycyrrhizic Acid / Q000008:administration & dosage* / Q000031:analogs & derivatives; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008168:Lung / Q000098:blood supply* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve; D011183:Postoperative Complications / Q000517:prevention & control; D015427:Reperfusion Injury / Q000517:prevention & control*
D019695:Glycyrrhizic Acid